Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), “silent” with mivacurium

Human butyrylcholinesterase Ala34Val variation (protein ribbon modal shown in blue) determines a silent phenotype yielding prolonged neuromuscular block after injection of mivacurium or succinylcholine.